| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IMVT | Immunovant, Inc. | Chief Financial Officer | $3.06M | May 1, 2025 | ||
| LABP | Landos Biopharma, Inc. | Director | May 23, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|